Commercial Products

Naltrexone HydrochlorideOpioid Antagonist

Naltrexone Hydrochloride is a medication primarily used to manage alcohol or opioid use disorder by reducing cravings and feelings of euphoria associated with substance use disorder. It has also been found to be effective in the treatment of other addictions.  An opioid-dependent person should not receive naltrexone before detoxification while effects begin within 30 minutes and a decreased desire for opioids may take a few weeks to occur. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias and stability tests of this API has been accomplished and confirmed.

Naltrexone BaseOpioid Antagonist

Naltrexone Base in similar to its salt, Naltrexone Hydrochloride and this Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias and stability tests of this API has been accomplished and confirmed.

TetrabenazineSedative-Hypotic

Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders.  On August 15, 2008, the U.S. Food and Drug Administration approved the use of tetrabenazine to treat chorea associated with Huntington's disease. Although other drugs had been used "off label," tetrabenazine was the first approved treatment for Huntington's disease in the United States. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias.

DeferasiroxIron Chelator

Deferasirox ‘s main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the United States for this purpose. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias.

AripiprazoleAtypical Antipsychotic

Aripiprazole is primarily used in the treatment of schizophrenia and bipolar disorder while other uses include as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism.  This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale. related analysis has been confirmed according to credible world pharmacopoeias.

Fluvoxamine MaleateAntidepressant

Fluvoxamine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and obsessive–compulsive disorder (OCD), but is also used to treat anxiety disorders such as panic disorder, social anxiety disorder, and post-traumatic stress disorder. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias.

Atorvastatin CalciumStatin

Atorvastatin is a statin medication used to prevent cardiovascular disease in those at high risk and to treat abnormal lipid levels. For the prevention of cardiovascular disease, statins are a first-line treatment.  This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias.

PregabalinAnticonvulsant

Pregabalin is an anticonvulsant, analgesic and anxiolytic medication used to treat epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, opioid withdrawal and generalized anxiety disorder (GAD).  Its use in epilepsy is as an add-on therapy for partial seizures. It is a gabapentinoid medication, which are a class of central nervous system depressants. When used before surgery, it reduces pain but results in greater sedation and visual disturbances. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias.

CelecoxibNSAID

Celecoxib is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis.  This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale and mass production scale. related analysis has been confirmed according to credible world pharmacopoeias.

PantoprazoleProton Pump Inhibitor

Pantoprazole is a proton pump inhibitor used for the treatment of stomach ulcers, short-term treatment of erosive esophagitis due to gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions including Zollinger–Ellison syndrome. It may also be used along with other medications to eliminate Helicobacter pylori.  This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale. related analysis has been confirmed according to credible world pharmacopoeias.

Tramadol HydrochlorideOpioid Pain Medication

Tramadol is an opioid pain medication used to treat moderate to moderately severe pain. When taken by mouth in an immediate-release formulation, the onset of pain relief usually begins within an hour. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale. related analysis has been confirmed according to credible world pharmacopoeias.

Pholcodine HydrochlorideAntitussive

Pholcodine is a drug which is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. This Active Pharmaceutical Ingredient has been synthesized in Soroush Mana Pharmed.

Dihydrocodeine BitartrateSemi-synthetic Opioid Analgesic

Dihydrocodeine is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with acetaminophen or aspirin. It was developed in Germany in 1908 and first marketed in 1911.  This Active Pharmaceutical Ingredient has been synthesized and related analysis has been confirmed according to credible world pharmacopoeias.

Nalbuphine HydrochlorideOpioid Analgesic

Nalbuphine is an opioid analgesic which is used in the treatment of pain. Side effects of nalbuphine include sedation, sweatiness, clamminess, nausea, vomiting, dizziness, vertigo, dry mouth, and headache. Unlike other opioids, it has little to no capacity for euphoria or respiratory depression. It also has little to no incidence of dysphoria, dissociation, hallucinations, and related side effects at typical therapeutic doses. Nalbuphine is a mixed agonist/antagonist opioid modulator. Specifically, it acts as a moderate-efficacy partial agonist or antagonist of the μ-opioid receptor (MOR) and as a high-efficacy partial agonist of the κ-opioid receptor (KOR), whereas it has relatively low affinity for the δ-opioid receptor (DOR) and sigma receptors. This Active Pharmaceutical Ingredient has been synthesized and manufactured in pilot scale.

Methyl Vinyl KetoneIntermediate

Methyl vinyl ketone (MVK, IUPAC name: butenone) is the organic compound with the formula CH3C(O)CH=CH2. It is a reactive compound classified as an enone, in fact the simplest example thereof. It is a colorless, flammable, highly toxic liquid with a pungent odor. It is soluble in water and polar organic solvents. It is a useful intermediate in the synthesis of other compounds.